2008 VIVA Satellite Symposium: The Next Frontier — Comprehensive State-of-the-Art Management of Critical Limb Ischemia

2008 VIVA Satellite Symposium: The Next Frontier—Comprehensive State-of-the-Art Management of Critical Limb Ischemia

Thursday, September 25, 2008, Las Vegas, NV

Critical limb ischemia (CLI) describes patients with chronic ischemic rest pain, ulcers, or gangrene attributed to peripheral artery disease. CLI represents a challenging population of patients with peripheral arterial disease (PAD). Affecting more than two million people in the United States, the prevalence of CLI is increasing in response to an aging population with an increasing prevalence of diabetes.
 

Agenda

Michael R. Jaff, DO, FACC, FAHA
Vascular Medicine    
Associate Professor of Medicine, Harvard Medical School    
Medical Director, Vascular Center, Massachusetts General Hospital
Boston, Massachusetts
Timothy M. Sullivan, MD, FACS, FSVM, FACC   
Vascular Surgery
Chairman, Vascular and Endovascular Surgery
Minneapolis Heart Institute® at Abbott Northwestern Hospital
Minneapolis, Minnesota
Krishna J. Rocha-Singh, MD, FACC
Interventional Cardiology   
Director, Vascular Medicine Program    
Prairie Heart Institute at St. John’s Hospital
Springfield, Illinois    
Douglas W. Losordo, MD, FACC
Interventional Cardiology
Director, Feinberg Cardiovascular Research Institute and Program in Cardiovascular Regenerative Medicine, Northwestern Memorial Hospital    
Chicago, Illinois 
Gary M. Ansel, MD, FACC, FAHA
Interventional Cardiology
Critical Limb Care Center
Riverside Methodist Hospital
Columbus, Ohio
By attending this symposium, participants will be better able to:   
1.   Understand the epidemiology, natural history, associated risks and methods of diagnosis for CLI
2.   Determine the role of surgical revascularization in patients with CLI.
3.   Explain the technical aspects and outcomes of current endovascular procedures for infrapopliteal disease.